Business

Novo Nordisk sues Dr. Reddy’s over Ozempic trademark(Soban News)

With semaglutide off-patent, a flood of low-cost generics is shifting the fight from molecules to brand names in India’s fast-growing weight-loss market

​With semaglutide off-patent, a flood of low-cost generics is shifting the fight from molecules to brand names in India’s fast-growing weight-loss market by Soban News (international And National News)

Related posts

Neonatal Sepsis Is Falling, But Not Everywhere – European Medical Journal(Soban News)

News-Soban-Admin

B2B fintechs turn to M&As to expand business lines and enter retail market

News-Soban-Admin

Severe AQI Hits Delhi, No Relief Expected Soon – Times of India(Soban News)

News-Soban-Admin

Leave a Comment